A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight

NCT06824051 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: Orforglipron
DRUG: Placebo

Sponsor

Eli Lilly and Company